By Whitney Webb for Mint Press News - So far, this year has not been very kind to Monsanto. First, collusion between Monsanto and the Environmental Protection Agency (EPA) was revealed, whereby the company worked in tandem with the federal agency to discredit independent research conducted by the World Health Organization’s International Agency for Research on Cancer (IARC). The IARC, in 2015, found that glyphosate – the key ingredient in Monsanto’s best-known product, Roundup — most likely causes cancer, a reality that Monsanto had secretly known for decades. Furthermore, Monsanto’s own head toxicologist, Donna Farmer, admitted that he “cannot say that Roundup does not cause cancer” as “we [Monsanto] have not done the carcinogenicity studies with Roundup.” With their lobbyists now banned from the EU parliament amid the body’s deliberations over whether to ban glyphosate entirely, Monsanto seems to be betting on the chemical it hopes will solve its glyphosate troubles — a herbicide known as dicamba. While dicamba has existed for decades, Monsanto has been busy retooling the herbicide, hoping to use it to replace glyphosate – not in response to concerns about glyphosate’s dangerous effects on human health but in order to tackle the development of widespread resistance to glyphosate among weeds in the United States and elsewhere. Monsanto has aggressively marketed its genetically modified, dicamba-tolerant seeds along with its associated herbicide, hoping to capture half of the entire U.S. soybean market by 2019.